New insights on the potential anti‐epileptic effect of metformin: Mechanistic pathway
Journal of Cellular and Molecular Medicine · 2023-12 · 27 (24) · 3953-3965
DOI: 10.1111/jcmm.17965 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 22.09.2023. Verfasst von Saud A Alnaaim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Neurosciences Department, College of Medicine, King Faisal University, Hofuf, Saudi Arabia. Hauptthemen laut MEDLINE: Metformin, Epilepsy. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Witten-Herdecke Germany..
Abstract (Originalsprache)
Epilepsy is a chronic neurological disease characterized by recurrent seizures. Epilepsy is observed as a well‐controlled disease by anti‐epileptic agents (AEAs) in about 69%. However, 30%–40% of epileptic patients fail to respond to conventional AEAs leading to an increase in the risk of brain structural injury and mortality. Therefore, adding some FDA‐approved drugs that have an anti‐seizure activity to the anti‐epileptic regimen is logical. The anti‐diabetic agent metformin has anti‐seizure activity. Nevertheless, the underlying mechanism of the anti‐seizure activity of metformin was not entirely clarified. Henceforward, the objective of this review was to exemplify the mechanistic role of metformin in epilepsy. Metformin has anti‐seizure activity by triggering adenosine monophosphate‐activated protein kinase (AMPK) signalling and inhibiting the mechanistic target of rapamycin (mTOR) pathways which are dysregulated in epilepsy. In addition, metformin improves the expression of brain‐derived neurotrophic factor (BDNF) which has a neuroprotective effect. Hence, metformin via induction of BDNF can reduce seizure progression and severity. Consequently, increasing neuronal progranulin by metformin may explain the anti‐seizure mechanism of metformin. Also, metformin reduces α‐synuclein and increases protein phosphatase 2A (PPA2) with modulation of neuroinflammation. In conclusion, metformin might be an adjuvant with AEAs in the management of refractory epilepsy. Preclinical and clinical studies are warranted in this regard.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Neurosciences Department, College of Medicine, King Faisal University, Hofuf, Saudi Arabia.
- Department of Clinical Pharmacology and Medicine, College of Medicine, ALmustansiriyia University, Baghdad, Iraq.
- Department of Internal Medicine, Medical College, Najran University, Najran, Saudi Arabia.
- Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, New South Wales, Australia.
- AFNP Med, Wien, Austria.
- Department of Surgery II, University Hospital Witten-Herdecke, University of Witten-Herdecke, Wuppertal, Germany.
ORCID-Profile: Athanasios Alexiou, Hebatallah M Saad
Förderung
- University of Witten-Herdecke Germany.
Zitieren
APA
Alnaaim, S. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Ali, N. H., Alexiou, A., Papadakis, M., Saad, H. M., & Batiha, G. E. (2023). New insights on the potential anti‐epileptic effect of metformin: Mechanistic pathway. Journal of Cellular and Molecular Medicine, 27(24), 3953-3965. https://doi.org/10.1111/jcmm.17965
Vancouver
Alnaaim SA, Al-Kuraishy HM, Al-Gareeb AI, Ali NH, Alexiou A, Papadakis M, et al. New insights on the potential anti‐epileptic effect of metformin: Mechanistic pathway. Journal of Cellular and Molecular Medicine. 2023;27(24):3953-3965. doi:10.1111/jcmm.17965
BibTeX
@article{Alnaaim2023,
author = {Alnaaim, Saud A and Al-Kuraishy, Hayder M and Al-Gareeb, Ali I and Ali, Naif H and Alexiou, Athanasios and Papadakis, Marios and Saad, Hebatallah M and Batiha, Gaber El-Saber},
title = {New insights on the potential anti‐epileptic effect of metformin: Mechanistic pathway},
journal = {Journal of Cellular and Molecular Medicine},
year = {2023},
volume = {27},
number = {24},
pages = {3953--3965},
doi = {10.1111/jcmm.17965}
}
EUVIMED